Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Daily News

Many ESC Guideline Recommendations Out of Reach in Poorer Regions

Michael O'Riordan

November 29, 2022

News Daily News

New Risk Models Superior to Pretest Probability at Predicting CAD

Yael L. Maxwell

November 15, 2022

News Daily News

Food Insecurity Rose Over the Past 20 Years in Patients With CVD

Yael L. Maxwell

September 29, 2022

News Conference News TCT 2022

PCSK9 Inhibitors Before PCI Swiftly Lower LDL-C in ACS Patients: EPIC-STEMI

Shelley Wood

September 22, 2022

News Daily News

AI-Enabled Algorithm Succeeds in Identifying Diabetes From ECG Data

Yael L. Maxwell

August 12, 2022

News Daily News

Cardiorespiratory Fitness Is Key to Longevity, Regardless of Age, Sex, and Race

Yael L. Maxwell

August 09, 2022

News Daily News

CV Risk Factors, Disease Projected to Explode in Coming Decades

L.A. McKeown

August 01, 2022

News Daily News

Black and Hispanic Patients Not Accessing High-Volume TEER Centers

Michael O'Riordan

July 19, 2022

News Daily News

Few Adults Eligible for Primary Prevention With Statins in Latest ESC Guidelines

Michael O'Riordan

July 06, 2022

News Daily News

‘Code Blue’ for the Dire CVD Health Status of Most US Adults

Michael O'Riordan

July 05, 2022

News Daily News

SURMOUNT-1: Tirzepatide Drastically Reduces Weight in Obese Patients

L.A. McKeown

June 09, 2022

News Conference News EAS 2022

Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering

Michael O'Riordan

May 24, 2022

News Daily News

For Coronary Heart Disease, Upping Exercise Over Time Linked to Survival Gains

Michael O'Riordan

May 03, 2022

News Conference News ACC 2022

What’s Going to Be Hot at ACC 2022, In Person or Virtual

Shelley Wood

March 28, 2022

News Daily News

Absence of CAC May be Protective Even in Patients With Very High Cholesterol

Michael O'Riordan

February 14, 2022

News Daily News

Homozygous FH Diagnosis Often Comes Late, With Lackluster Care

Michael O'Riordan

February 10, 2022

News Features

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

Michael O'Riordan

January 17, 2022

Advertisement

Many ESC Guideline Recommendations Out of Reach in Poorer Regions

New Risk Models Superior to Pretest Probability at Predicting CAD

Food Insecurity Rose Over the Past 20 Years in Patients With CVD

PCSK9 Inhibitors Before PCI Swiftly Lower LDL-C in ACS Patients: EPIC-STEMI

AI-Enabled Algorithm Succeeds in Identifying Diabetes From ECG Data

Cardiorespiratory Fitness Is Key to Longevity, Regardless of Age, Sex, and Race

CV Risk Factors, Disease Projected to Explode in Coming Decades

Black and Hispanic Patients Not Accessing High-Volume TEER Centers

Few Adults Eligible for Primary Prevention With Statins in Latest ESC Guidelines

‘Code Blue’ for the Dire CVD Health Status of Most US Adults

SURMOUNT-1: Tirzepatide Drastically Reduces Weight in Obese Patients

Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering

For Coronary Heart Disease, Upping Exercise Over Time Linked to Survival Gains

What’s Going to Be Hot at ACC 2022, In Person or Virtual

Absence of CAC May be Protective Even in Patients With Very High Cholesterol

Homozygous FH Diagnosis Often Comes Late, With Lackluster Care

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content